[REGN] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
07-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -43.80%
YoY- -3.53%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 2,965,100 2,528,700 1,828,200 1,711,800 1,511,485 1,318,991 1,200,849 16.25%
PBT 1,061,100 1,253,000 668,600 546,100 585,398 432,289 330,151 21.46%
Tax 87,600 137,800 44,000 85,000 107,418 183,358 164,415 -9.95%
NP 973,500 1,115,200 624,600 461,100 477,980 248,931 165,736 34.30%
Tax Rate -8.26% -11.00% -6.58% -15.56% -18.35% -42.42% -49.80% -
Total Cost 1,991,600 1,413,500 1,203,600 1,250,700 1,033,505 1,070,060 1,035,113 11.51%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin 32.83 44.10 34.16 26.94 31.62 18.87 13.80 15.53%
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS 8.61 10.58 5.69 4.23 4.44 2.36 1.74 30.52%
EPS Diluted 8.61 10.09 5.43 3.99 4.16 2.16 1.59 32.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.